High Efficacy and Favorable Safety of ABT-493 and ABT-530 Co-Administration for 12 Weeks in HCV Genotype 1-Infected Patients with Cirrhosis (Surveyor-I)E. Gane, F. Poordad,A. Asatryan,J. Lalezari, T. Hassanein,H. Aguilar,T.I. Ng,Ran Liu,C.-W. Lin, J. Kort,F. MensaJOURNAL OF HEPATOLOGY（2016）引用 2|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
